Intracellular disposition of arabinogalactan and asialofetuin in HepG2 cells

被引:8
作者
Tanaka, T. [1 ]
Abo, Y. [1 ]
Hamano, S. [1 ]
Fujishima, Y. [1 ]
Kaneo, Y. [1 ]
机构
[1] Fukuyama Univ, Fac Pharm & Pharmaceut Sci, Dept Biopharmaceut, Fukuyama, Hiroshima 7290292, Japan
关键词
Arabinogalactan; Asialofetuin; HepG2; cells; Intracellular disposition; HEPATIC BINDING-PROTEIN; RAT HEPATOCYTES; ASIALOGLYCOPROTEIN RECEPTOR; LIVER; CONJUGATE; DELIVERY; CARRIER;
D O I
10.1016/S1773-2247(13)50062-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The binding and uptake of arabinogalactan and asialofetuin in HepG2 cells was kinetically characterized using I-125-labeled ligands. The number of binding sites (n) and the association constant (K-a) of arabinogalactan was 1.9 x 10(5) +/- 1.2 x 10(5) sites/cell and 5.0 x 10(6) +/- 3.9 x 10(6) M-1, respectively, whereas the n and K-a of asialofetuin was 2.7 x 10(5) +/- 1.1 x 10(5) sites/cell and 1.1 x 10(7) +/- 0.7 x 10(7) M-1, respectively. These results suggest that the binding capacity of HepG2 cells for arabinogalactan is lower than that for asialofetuin. Moreover, the amount of arabinogalactan uptake by HepG2 cells was lower than that of asialofetuin. Thus, asialofetuin was preferentially bound and internalized by hepatoma cells compared to arabinogalactan.
引用
收藏
页码:435 / 438
页数:4
相关论文
共 19 条
  • [1] A novel injectable water-soluble amphotericin B-arabinogalactan conjugate
    Falk, R
    Domb, AJ
    Polacheck, I
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1975 - 1981
  • [2] RECEPTOR-MEDIATED INTRODUCTION OF PEPSTATIN-ASIALOFETUIN CONJUGATE INTO LYSOSOMES OF RAT HEPATOCYTES
    FURUNO, K
    MIWA, N
    KATO, K
    [J]. JOURNAL OF BIOCHEMISTRY, 1983, 93 (01) : 249 - 256
  • [3] PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY
    GREENWOOD, FC
    HUNTER, WM
    [J]. BIOCHEMICAL JOURNAL, 1963, 89 (01) : 114 - &
  • [4] ARABINOGALACTAN FOR HEPATIC DRUG-DELIVERY
    GROMAN, EV
    ENRIQUEZ, PM
    JUNG, C
    JOSEPHSON, L
    [J]. BIOCONJUGATE CHEMISTRY, 1994, 5 (06) : 547 - 556
  • [5] Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats
    Kaneo, Y
    Ueno, T
    Tanaka, T
    Iwase, H
    Yamaguchi, Y
    Uemura, T
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 201 (01) : 59 - 69
  • [6] KANEO Y, 1991, CHEM PHARM BULL, V39, P999
  • [7] LeveilleWebster CR, 1996, HEPATOLOGY, V23, P1631, DOI 10.1053/jhep.1996.v23.pm0008675187
  • [8] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [9] GLYCOCONJUGATES AS CARRIERS FOR SPECIFIC DELIVERY OF THERAPEUTIC DRUGS AND GENES
    MONSIGNY, M
    ROCHE, AC
    MIDOUX, P
    MAYER, R
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1994, 14 (01) : 1 - 24
  • [10] Preparation of dendritic graft copolymer consisting of poly(L-lysine) and arabinogalactan as a hepatocyte specific dna carrier
    Park, JU
    Ishihara, T
    Kano, A
    Akaike, T
    Maruyama, A
    [J]. PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 1999, 29 (04) : 353 - 370